Daaco, Irine Kate .

HRN: 15-39-50  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2023
CEFUROXIME 750MG (VIAL)
11/27/2023
12/03/2023
IVT
500mg
Q8
Pneumonia, UTI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: